Pediatric cancer research: Surviving COVID‐19

A diverse panel of pediatric cancer advocates and experts, whose collective experience spans the continuum of international academic medicine, industry, government research, and cancer advocacy, recently discussed challenges for pediatric cancer research in the context of coronavirus disease 2019 (C...

Full description

Saved in:
Bibliographic Details
Published in:Pediatric Blood & Cancer 2020-09, Vol.67 (9), p.e28435-n/a
Main Authors: Auletta, Jeffery J., Adamson, Peter C., Agin, Jonathan E., Kearns, Pamela, Kennedy, Scott, Kieran, Mark W., Ludwinski, Donna M., Knox, Leona J., McKay, Kristi, Rhiner, Pia, Thiele, Carol J., Cripe, Timothy P.
Format: Article
Language:English
Subjects:
Adolescent
advocacy
Betacoronavirus - metabolism
Cancer
Cancer research
Child
Child, Preschool
coronavirus
Coronavirus Infections - epidemiology
Coronavirus Infections - metabolism
Coronavirus Infections - pathology
Coronavirus Infections - therapy
Coronaviruses
COVID-19
Female
Hematology
Humans
Infant
inflammation
Male
Medical expense insurance
Medical research
Neoplasms - epidemiology
Neoplasms - metabolism
Neoplasms - pathology
Neoplasms - therapy
Oncology
Pandemics
Pediatrics
Pneumonia, Viral - epidemiology
Pneumonia, Viral - metabolism
Pneumonia, Viral - pathology
Pneumonia, Viral - therapy
Recovery (Medical)
relapse
SARS-CoV-2
Special Report
Special Reports
systemic acute respiratory syndrome
Translational Research, Biomedical
tumor
Tumorigenesis
Citations: Items that this one cites
Items that cite this one
Online Access:Request full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A diverse panel of pediatric cancer advocates and experts, whose collective experience spans the continuum of international academic medicine, industry, government research, and cancer advocacy, recently discussed challenges for pediatric cancer research in the context of coronavirus disease 2019 (COVID‐19). Specifically, this special report addresses the following focus areas: (a) the critical role that translational research has played in transforming pediatric cancer outcomes; (b) the current and potential future impact of COVID‐19 on pediatric cancer research; (c) target areas of COVID‐19 research that may have application in immunity, oncogenesis, and therapeutic discovery; and (d) future considerations and directions in maintaining pediatric cancer research during and after COVID‐19.
ISSN:1545-5009
1545-5017
DOI:10.1002/pbc.28435